Subscribe to the Daily PV Brief for breaking drug safety news, regulatory updates, and pharmacovigilance insights.
Daily News and Intelligence for the Pharmacovigilance Industry
Stay informed with timely coverage of drug safety, regulatory developments, safety signals, inspections, AI in pharmacovigilance, compliance trends, and career insights from across the global PV landscape.
MHRA and NICE Launch Faster Joint Approval Pathway
MHRA and NICE say their new aligned pathway could bring some medicines to patients in England three to six months earlier.
Today in PV
A quick scan of the latest stories, safety concerns, regulatory developments, and industry signals every pharmacovigilance professional should know today.
Explore Coverage
Browse the key areas shaping pharmacovigilance today, from global regulatory updates to safety signals, compliance trends, AI, and career growth.
Regulatory Updates
Track key developments from FDA, EMA, MHRA, WHO, NAFDAC, Health Canada, TGA, SAHPRA, and other health authorities.
Inspections & Compliance
Stay current on inspection readiness, CAPAs, SOP expectations, audit trends, and the compliance issues shaping PV systems.
Explainers
Clear, practical breakdowns of PV concepts, industry terms, reporting frameworks, and regulatory changes.
Careers
Insights for professionals building or advancing careers in pharmacovigilance, drug safety, compliance, and related functions.
Safety Signals
Follow emerging risks, label changes, recalls, medication errors, and other safety issues that matter in real-world pharmacovigilance.
AI & Digital PV
Explore how artificial intelligence, automation, and digital tools are influencing case processing, signal detection, and safety operations.
Latest News
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam. Aque ipsa quae ab illo inventore veritatis. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accus antium doloremque.
Why E2B(R3) and EVWEB Skills Still Open Doors in 2026
In a year full of AI discussion, EMA’s 2026 training agenda is a useful reminder that strong reporting fundamentals still matter.
Why AI Governance Is Becoming a Differentiator in PV Careers
In regulated environments, knowing how to use AI is helpful. Knowing how to govern it may become even more valuable.
A Missing PIL Warning, a GPvP Inspection, and a Bigger Compliance Lesson
An MHRA defect notification linked missing leaflet safety information to a GPvP inspection, offering a useful reminder that pharmacovigilance findings can surface in product-facing materials.
Why EudraVigilance Training Is a Compliance Requirement in Practice
MA’s EudraVigilance framework makes a clear point: in regulated safety systems, training is not just onboarding. It is part of operational control.
What the Amended CIR 520/2012 Means for Some UK-Authorised Products
The UK has its own regulatory system, but the February 2026 amendments to EU CIR 520/2012 still carry practical implications for some UK-authorised medicines.
Why MedWatch Still Matters in the Age of Digital Safety Platforms
Even as FDA modernizes with AEMS, MedWatch remains a key public-facing route for reporting serious safety problems and distributing safety alerts.
Featured Posts
Why AI Governance Is Becoming a Career Advantage in Pharmacovigilance
As AI spreads through regulated workflows, pharmacovigilance professionals who understand governance, documentation, and context of use may become more valuable than those who only know the tools.
Patent Expirations Are Pushing Biopharma Toward a Tougher 2026 — Why PV Teams Should Pay Attention
Patent expirations and slower growth forecasts are putting pressure on biopharma in 2026. Here’s why pharmacovigilance teams should pay attention.
FDA Recommends Earlier MRI Monitoring for Patients Taking Leqembi
The U.S. Food and Drug Administration has said it is recommending an additional, earlier MRI for patients with Alzheimer’s disease taking Leqembi (lecanemab). The agency stated that this added MRI should occur before the 3rd infusion, in addition to the monitoring...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Contact us
Email Us
editor@pvwatchdaily.com